We previously reported that the intratumoral administration of the TLR3 ligand poly(I:C), the TLR7/8 ligand R848 and the chemokine MIP3α, co-encapsulated in a nanoparticle, is more effective in murine cancer models than either agent encapsulated alone [19,20]. This evidence concerns the gene TLR3 and cancer.